Ables Iannone Moore & Associates’s Amgen AMGN Stock Holding History

Ables Iannone Moore & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.08M	Sell	2,558 -300	-10%	-$120K	0.56%	33
2026 Q2	$1.04M	Hold	2,858	–	–	0.55%	33
2026 Q1	$1.01M	Sell	2,858 -275	-9%	-$98K	0.6%	34
2025 Q4	$1.03M	Sell	3,133 -101	-3%	-$32K	0.56%	34
2025 Q3	$913K	Sell	3,234 -110	-3%	-$31.9K	0.52%	34
2025 Q2	$934K	Sell	3,344 -16	-0.5%	-$4.53K	0.58%	35
2025 Q1	$1.05M	Sell	3,360 -5	-0.1%	-$1.48K	0.71%	30
2024 Q4	$877K	Buy	3,365 +1	+0%	+$297	0.54%	34
2024 Q3	$1.08M	Hold	3,364	–	–	0.7%	30
2024 Q2	$1.05M	Sell	3,364 -31	-0.9%	-$9.11K	0.7%	30
2024 Q1	$965K	Hold	3,395	–	–	0.69%	31
2023 Q4	$978K	Buy	+3,395	New	+$925K	0.75%	28

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Ables Iannone Moore & Associates's AMGN Position: Q3 2026 in Review

Ables Iannone Moore & Associates reduced its Amgen (AMGN) stake by 10% in Q3 2026, selling an estimated $120K and leaving 2,558 shares worth $1.08M. The position accounts for 0.56% of the portfolio, ranked #33.

Ables Iannone Moore & Associates first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.08M in Q3 2024. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Ables Iannone Moore & Associates held 2,558 shares of Amgen worth $1.08M as of Q3 2026.
Ables Iannone Moore & Associates sold 300 Amgen shares in Q3 2026, an estimated $120K.
Amgen made up 0.56% of Ables Iannone Moore & Associates's portfolio in Q3 2026, its #33 holding.
Ables Iannone Moore & Associates first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
Ables Iannone Moore & Associates's Amgen position peaked at $1.08M in Q3 2024.
2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Ables Iannone Moore & Associates's 13F filing for Q3 2026, filed 6 Oct 2026.